Economics of Innovation
Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.
Projecting Expenditure on Medicines in the NHS
4 January 2013
Medicines account for less than 10% of total NHS expenditure in the UK. Because spending on medicines is easy to separate out, however, this sector continues…
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
How much it costs to research and develop a successful new medicine has been an important policy issue at least since the 1960s. Cost estimates matter…
New Study of Time Lags in Translating Medical Research into Practice
30 November 2012
One of the greatest challenges in biomedical and health research is ensuring that research findings are translated effectively and without undue delay from ‘bench to bedside’.…
Value Based Pricing in Sweden: Lessons for Design?
28 November 2012
OHE has just published a Seminar Briefing by Ulf Persson, head of the Swedish Institute of Health Economics, which reviews experience with the Swedish value based…
Tracking Changes in the Causes of Death in England and Wales
25 October 2012
OHE’s health and health care statistics service long has been respected as a source of reliable data. In an OHE Briefing just published, OHE uses this…
Join OHE in a Seminar to Discuss IP, Innovation and the Human Genome
19 October 2012
In this OHE lunchtime seminar, Prof Heidi Williams of MIT will present the results of a recent paper using newly-collected data on the sequencing of the…
Meeting the Challenges of Drug Development in 2022: Summary of OHE’s 50th Anniversary Conference
11 October 2012
To celebrate its 50th Anniversary, OHE held a conference this week, The Challenges and Economics of Drug Development in 2022, which explored the likely evolution of…
OHE’s 50th Celebration: Publications on Tuberculosis Show Constancy and Change
23 August 2012
Between 1962 and 1998, OHE published more than 100 booklets on various diseases and conditions as part of a series on “current health problems”. The first…
Register Now: OHE Lunchtime Seminar on Innovation
26 June 2012
In response to the R&D productivity crisis affecting the pharmaceutical industry, “big pharma” is seeking to source therapeutics from small and medium sized enterprises (SMEs). In…